Ranbaxy Laboratories has acquired Be-Tabs Pharmaceuticals, the fifth-largest generics company in South Africa, for $70 million.
Ranbaxy Laboratories, the country's biggest drugmaker, is all set to focus its energies in developing and marketing niche products where price erosion is minimal
Abbott Laboratories is suing India's Ranbaxy Laboratories as well as Israel's Teva and Sandoz of the Novartis group, in Chicago for allegedly violating its patents protecting Omnicef, a drug used to treat ear, throat and skin infections.
Amid reports of a possible delay in release of spectrum by the defence forces, DoT is going ahead with regulator Telecom Regulatory Authority of India's recommendations on auctioning the airwaves with a reserve base price.
A new study reveals how drug brand names are hijacked by online pharmacies that churn out spam e-mails and hawk counterfeit pills.
As per the new guidelines, the wholesalers will get 15 per cent margin while retailers will 35 per cent over the cost of manufacturing of generic medicines, Minister of Chemicals and Fertiliser Ram Vilas Paswan told reporters.
Pharmaceutical company Unichem Laboratories Ltd said on Friday it has entered into a product development, manufacturing and supply agreement with US-based PLIVA Inc.
Etiquette classes today cater to a wide audience of job seekers, front-desk execs, business heirs, romantics, students and even those with low self-esteem
The Chief Minister's Free Medicine Scheme in Rajasthan is probably the most successful scheme introduced by the Ashok Gehlot government in the state. Now poll politics has cast a shadow over the scheme
Pharma major, Wockhardt Ltd on Tuesday announced the acquisition of Ireland's leading generic pharmaceutical company Pinewood Laboratories Ltd for over Rs 686 crore
India's largest drug maker Ranbaxy was at the receiving end of two patent infringement cases in Denmark and the USA on February 23
Mumbai-based pharmaceutical company Indoco Remedies Ltd plans to tap the regulated markets of Europe and the US.
Strides Arcolab Ltd's, US subsidiary Strides Inc and STADA Pharmaceuticals Inc, the US subsidiary of STADA Arzneimittel AG, have signed a development and supply agreement for a prescription generic drug product for the US market.
While the domestic industry needs to increase its R&D spending quite dramatically, price controls will only cripple the sector.
As part of its global expansion plans, Dabur Pharma has acquired the sales and distribution network of Thailand-based Bioscience for an undisclosed sum.
Financials were the top losers while oil shares also declined amid weak crude oil prices.
Ranbaxy Laboratories will soon join the select club of Indian pharmaceutical majors and have a share in the $76.6 million generics market for anti-infective Cefprozil tablets in the US.
In a landmark judgment likely to benefit Indian generic drug manufacturers in a big way, the US Supreme Court has ruled against patenting of products with slight modifications.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances